Shield Therapeutics Share Discussion Threads

[washingmachine] 26/4/2024 11:24

Note
A director bought 2 million shares at 6 pence only back in November 2023
Could you be 5 X out on market value five months later

[washingmachine] 26/4/2024 11:04

Review
I’ve scrolled right back on the thread
You were Uber bullish like everyone else on here , the share price at the time was over 6 pence
Only two names were fighting against the tide
at the time
Who were both lambasted and ridiculed by the thread
Wally and Amaretto
Scroll back , very sobering.
R/W L at Price today

[qipincha] 26/4/2024 10:39

I disagree management is everything. Absolutely not. You can’t do business with just management…

[reviewwworld] 26/4/2024 09:51

Unfortunately my memory of your posts is relentless bullishness even in the face of dire company announcements you've always tried to spin positively.Saying only problem is management is like the only problem about breathing being a lack of oxygen.Management is everything

[washingmachine] 26/4/2024 09:29

I’m sure their is a minimum AOP buy out price
Memory recalls 3 pence

[jimduggen] 26/4/2024 09:26

The ip is worth £100 mill plus alone.

Crazy low price.

[washingmachine] 26/4/2024 09:24

Risk / reward firmly to the latter

[qipincha] 26/4/2024 09:11

I have different thinking around the risks. The company has already passed several risky periods, better than many start up companies. And the product is on the market and the demand is there. The only problem is the management, as we know, the BOD underestimated the complexity of selling in US and the cost! Plus impact of COVID! It is shame they are still paid with good salary!

[reviewwworld] 25/4/2024 13:21

Re the buyers... Given company history, this is an extremely high risk investment that is either on the "punt" side of things or a major shareholder is averaging down and relentlessly believes the story can be turned around.It's a value trap here and all about balance of probabilities. This forum is filled with endless hope about the wonderful product and what it COULD achieve. I get all that, hence I invested. But when you're in a death spiral of seemingly endless dilution and consistent horrendous corporate strategy, you'd be ignorant to buy it solely on the merit of it's one product (that is a ticking time bomb re patent life albeit a long one).What we've got here is Michael Phelps living in the middle of the desert.

[qipincha] 25/4/2024 12:49

Don’t think it still makes sense to do fund raising, more realistic with short term borrowing if they need. This is something I am hoping to find out from their update.

[bos1234] 25/4/2024 12:26

Reviewworld, so who do you think are buying all the shares that are being sold and why are they buying them?

[weatherman] 25/4/2024 12:20

Are we looking at 2 for 1 dilution at 1p ? :( - hope not, but not looking good.

[qipincha] 25/4/2024 12:20

I don’t think share price is always a good indicator, especially for SMEs, the price can be easily manipulated.

[reviewwworld] 25/4/2024 12:09

The share price sadly indicates otherwise.If there is one thing we have learnt about this sinking ship is that it's a very leaky one. Every single announcement by the company of the past 2 years has seen selling beforehand that has proven to be "smart" sales.This move today, in decent volume, just confirms the narrative. Every announcement I report to the FCA for insider dealing but yet to receive a response/investigation.Regardless, don't be surprised when the 30th comes with even more value destruction for us retail investors

[bos1234] 25/4/2024 11:48

It takes hundreds of millions of dollars to bring a new drug to the market. Shield has rights to the IPR protected until 2035. Has launched the product and has a rapidly expanding market. Has major shareholders who have invested millions and millions of dollars into this company. I do not know what will happen in the next 12 months but I think it is inconceivable that the major shareholders will shrug their shoulders, walk away and let it go bankrupt.

[ih_676530] 25/4/2024 11:09

The share price is heavily oversold on the tech chart,especially after today's drop. This should draw in value and chart traders. If Tuesday's results are as good as February's trading update then the share price could easily double in value in a single day.

[qipincha] 25/4/2024 10:56

This is already known. Nothing new

[tripletop1] 25/4/2024 10:50

all started with the insider selling ahead of the fundraise when the share price was at 12.5p end Sept.

that should have been the moment to bail..

[r9505571] 25/4/2024 08:00

Consensus revenue estimates fall by 19%The consensus outlook for revenues in fiscal year 2023 has deteriorated.2023 revenue forecast decreased from US$15.3m to US$12.4m.Forecast losses increased from -US$0.037 to -US$0.039 per share.Pharmaceuticals industry in the United Kingdom expected to see average net income growth of 37% next year.Consensus price target down from UK£0.15 to UK£0.02.Share price fell 3.7% to UK£0.014 over the past week.

[cordwainer] 24/4/2024 16:07

Re review world, conversation = "let's make a lowball offer for the rest of the shares which this weak and shareholer unfriendly mgmt will accept and who cares about the small retail shareholders.. "

[reviewwworld] 24/4/2024 15:29

If you're the major shareholder, I wonder what conversation you're having internally